Used as a key chiral intermediate in the synthesis of pharmaceuticals, particularly in the development of protease inhibitors and antiviral agents. Its fluorinated piperidine structure enhances metabolic stability and bioavailability in drug candidates. Commonly employed in the preparation of active pharmaceutical ingredients (APIs) for treatments targeting hepatitis C and other viral diseases. The presence of both amine and fluorine functionalities allows for selective derivatization, making it valuable in medicinal chemistry for structure-activity relationship (SAR) studies.